TGFB1 and infection: In our study, we specifically addressed this by using the TGF-β inhibitor Repsox and found that its effects on HIV-1 replication—whether wild-type or Vpr-deficient—do not clearly distinguish between cell-intrinsic (infection-induced) and exogenously supplied TGF-β.